We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.15B
AUM Growth
-$3.94B
Cap. Flow
-$4.44B
Cap. Flow %
-106.94%
Top 10 Hldgs %
33.3%
Holding
6,378
New
470
Increased
1,548
Reduced
3,513
Closed
532

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$61.6M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$32.2M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$21.8M
4
USO icon
United States Oil Fund
USO
+$12.8M
5
XLB icon
State Street Materials Select Sector SPDR ETF
XLB
+$11.4M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$263M
2
AAPL icon
Apple
AAPL
+$226M
3
AMZN icon
Amazon
AMZN
+$127M
4
NVDA icon
NVIDIA
NVDA
+$115M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$80.9M

Sector Composition

Rank Sector Weight
1 Technology 26.16%
2 Consumer Discretionary 9.21%
3 Communication Services 8.49%
4 Financials 7.96%
5 Industrials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBIT icon
3901
XBiotech
XBIT
$75M
$9.08K ﹤0.01%
1,117
+1,065
+2,048% +$6.1K
VAXX
3902
DELISTED
Vaxxinity, Inc. Class A Common Stock
VAXX
$9.08K ﹤0.01%
12,640
+58
+0.5% +$42
VIRX
3903
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$9.07K ﹤0.01%
8,889
-5,109
-36% -$3.73K
FINW icon
3904
FinWise Bancorp
FINW
$191M
$9.06K ﹤0.01%
902
+778
+627% +$9.09K
OSUR icon
3905
OraSure Technologies
OSUR
$277M
$9.06K ﹤0.01%
1,474
-28,352
-95% -$206K
HLVX
3906
DELISTED
HilleVax
HLVX
$9.06K ﹤0.01%
545
-1,911
-78% -$30.6K
GHM icon
3907
Graham Corp
GHM
$1.33B
$9.06K ﹤0.01%
332
+132
+66% +$2.96K
RMCF icon
3908
Rocky Mountain Chocolate Factory
RMCF
$15.6M
$9.05K ﹤0.01%
2,501
+1,235
+98% +$5.14K
BBLG
3909
Bone Biologics
BBLG
$1.22M
$9.05K ﹤0.01%
708
+504
+247% +$9.84K
PAA icon
3910
Plains All American Pipeline
PAA
$16.5B
$9.04K ﹤0.01%
515
-2,888
-85% -$46.6K
VRCA icon
3911
Verrica Pharmaceuticals
VRCA
$83.5M
$9.04K ﹤0.01%
153
-51
-25% -$2.81K
WORX
3912
DELISTED
SCWORX CORP NEW
WORX
$9.04K ﹤0.01%
200
+39
+24% +$1.02K
FISI icon
3913
Financial Institutions
FISI
$825M
$9.03K ﹤0.01%
480
-1,055
-69% -$20.9K
TPCS icon
3914
TechPrecision Corp
TPCS
$48.5M
$9.02K ﹤0.01%
2,498
+1,850
+285% +$7.42K
OBIO icon
3915
Orchestra BioMed
OBIO
$266M
$9.02K ﹤0.01%
1,711
-757
-31% -$5.13K
NXTS
3916
Nexentis Technologies
NXTS
$2.67M
$9.02K ﹤0.01%
29
+9
+45% +$3.5K
GHSI
3917
DELISTED
Guardion Health Sciences, Inc. Common Stock
GHSI
$9.01K ﹤0.01%
998
-140
-12% -$1.03K
ECOR icon
3918
electroCore
ECOR
$84.7M
$9K ﹤0.01%
1,459
-60
-4% -$405
CHCI icon
3919
Comstock Holding Companies
CHCI
$152M
$8.99K ﹤0.01%
1,767
-196
-10% -$931
ALPP
3920
DELISTED
Alpine 4 Holdings Inc
ALPP
$8.99K ﹤0.01%
12,680
+4,067
+47% +$2.81K
SPRB
3921
Spruce Biosciences
SPRB
$135M
$8.98K ﹤0.01%
+152
New +$38.7K
TWKS
3922
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$8.98K ﹤0.01%
3,549
-20,236
-85% -$77.6K
OGI
3923
Organigram Holdings
OGI
$177M
$8.97K ﹤0.01%
4,172
+2,584
+163% +$5K
PBYI icon
3924
Puma Biotechnology
PBYI
$450M
$8.97K ﹤0.01%
1,692
-1,110
-40% -$5.98K
LYEL icon
3925
Lyell Immunopharma
LYEL
$347M
$8.95K ﹤0.01%
201
-1,451
-88% -$62.1K
155 156
157
158 159

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2024 Portfolio in Review

As of Q1 2024, Tower Research Capital (TRC) held 6,378 positions worth $4.15B, down 49% from $8.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.44B in Q1 2024, closing 532 positions and reducing 3,513 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $49.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares S&P Small-Cap 600 Growth ETF worth $3.77M.

  • Tower Research Capital (TRC)'s largest Q1 2024 buy was iShares S&P Small-Cap 600 Growth ETF: 28,851 shares worth $3.77M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q1 2024, an estimated $61.6M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2024 reduction was Microsoft, cutting an estimated $263M.
  • Tower Research Capital (TRC) fully exited State Street Financial Select Sector SPDR ETF in Q1 2024, selling an estimated $49.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 33% of its $4.15B portfolio in Q1 2024.
  • Tower Research Capital (TRC) opened 470 new positions and closed 532 in Q1 2024.
  • Tower Research Capital (TRC)'s portfolio value fell 49% quarter-over-quarter to $4.15B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.